Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1995 Jul;101(Suppl 1):23–26. doi: 10.1111/j.1365-2249.1995.tb06158.x

The treatment of Wegener's granulomatosis.

R A DeRemee 1
PMCID: PMC1553553  PMID: 7541733

Full text

PDF
23

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allen N. B., Caldwell D. S., Rice J. R., McCallum R. M. Cyclosporin A therapy for Wegener's granulomatosis. Adv Exp Med Biol. 1993;336:473–476. doi: 10.1007/978-1-4757-9182-2_85. [DOI] [PubMed] [Google Scholar]
  2. Alloway J. A., Cupps T. R. High dose methylprednisolone for retroorbital Wegener's granulomatosis. J Rheumatol. 1993 Apr;20(4):752–754. [PubMed] [Google Scholar]
  3. Andrassy K. Therapeutic modalities in patients with generalized Wegener's granulomatosis (WG) and related diseases. APMIS Suppl. 1990;19:47–47. doi: 10.1111/j.1600-0463.1990.tb05734.x. [DOI] [PubMed] [Google Scholar]
  4. Briedigkeit L., Ulmer M., Rheinhold-Keller E., Göbel U., Natusch R., Gross W. L. Die Therapie der Wegenerschen Granulomatose. Erfahrungen mit der konventionellen und der stadienadaptierten Behandlung bei 111 Patienten während 24 Jahren. Z Gesamte Inn Med. 1993 Apr;48(4):183–189. [PubMed] [Google Scholar]
  5. Capizzi R. L., Bertino J. R. Methotrexate therapy of Wegener's granulomatosis. Ann Intern Med. 1971 Jan;74(1):74–79. doi: 10.7326/0003-4819-74-1-74. [DOI] [PubMed] [Google Scholar]
  6. Chapman P. T., O'Donnell J. L. Respiratory failure in Wegener's granulomatosis: response to pulse intravenous methylprednisolone and cyclophosphamide. J Rheumatol. 1993 Mar;20(3):504–506. [PubMed] [Google Scholar]
  7. Daum T. E., Specks U., Colby T. V., Edell E. S., Brutinel M. W., Prakash U. B., DeRemee R. A. Tracheobronchial involvement in Wegener's granulomatosis. Am J Respir Crit Care Med. 1995 Feb;151(2 Pt 1):522–526. doi: 10.1164/ajrccm.151.2.7842215. [DOI] [PubMed] [Google Scholar]
  8. DeRemee R. A. The nosology of Wegener's granulomatosis utilizing the elk format augmented by c-ANCA. Adv Exp Med Biol. 1993;336:209–215. doi: 10.1007/978-1-4757-9182-2_31. [DOI] [PubMed] [Google Scholar]
  9. DeRemee R. A. Wegener granulomatosis. Ann Intern Med. 1992 Oct 1;117(7):619–621. [PubMed] [Google Scholar]
  10. Fauci A. S., Haynes B. F., Katz P., Wolff S. M. Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med. 1983 Jan;98(1):76–85. doi: 10.7326/0003-4819-98-1-76. [DOI] [PubMed] [Google Scholar]
  11. Frascà G. M., Zoumparidis N. G., Borgnino L. C., Neri L., Vangelista A., Bonomini V. Plasma exchange treatment in rapidly progressive glomerulonephritis associated with anti-neutrophil cytoplasmic autoantibodies. Int J Artif Organs. 1992 Mar;15(3):181–184. [PubMed] [Google Scholar]
  12. GODMAN G. C., CHURG J. Wegener's granulomatosis: pathology and review of the literature. AMA Arch Pathol. 1954 Dec;58(6):533–553. [PubMed] [Google Scholar]
  13. Gremmel F., Druml W., Schmidt P., Graninger W. Cyclosporin in Wegener granulomatosis. Ann Intern Med. 1988 Mar;108(3):491–491. doi: 10.7326/0003-4819-108-3-491_1. [DOI] [PubMed] [Google Scholar]
  14. Guillevin L., Rosser J., Cacoub P., Mousson C., Jarrousee B. Methylprednisolone in the treatment of Wegener's granulomatosis, polyarteritis nodosa and Churg-Strauss angiitis. APMIS Suppl. 1990;19:52–53. doi: 10.1111/j.1600-0463.1990.tb05737.x. [DOI] [PubMed] [Google Scholar]
  15. Généreau T., Lortholary O., Leclerq P., Grenet D., Tubéry M., Sicard D., Caubarrère I., Guillevin L. Treatment of systemic vasculitis with cyclophosphamide and steroids: daily oral low-dose cyclophosphamide administration after failure of a pulse intravenous high-dose regimen in four patients. Br J Rheumatol. 1994 Oct;33(10):959–962. doi: 10.1093/rheumatology/33.10.959. [DOI] [PubMed] [Google Scholar]
  16. Haga H. J., D'Cruz D., Asherson R., Hughes G. R. Short term effects of intravenous pulses of cyclophosphamide in the treatment of connective tissue disease crisis. Ann Rheum Dis. 1992 Jul;51(7):885–888. doi: 10.1136/ard.51.7.885. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Harley N., Ihle B. Wegener's granulomatosis--use of cyclosporin-A: a case report. Aust N Z J Med. 1990 Feb;20(1):71–73. doi: 10.1111/j.1445-5994.1990.tb00376.x. [DOI] [PubMed] [Google Scholar]
  18. Haubitz M., Frei U., Rother U., Brunkhorst R., Koch K. M. Cyclophosphamide pulse therapy in Wegener's granulomatosis. Nephrol Dial Transplant. 1991;6(8):531–535. doi: 10.1093/ndt/6.8.531. [DOI] [PubMed] [Google Scholar]
  19. Hoffman G. S., Leavitt R. Y., Fleisher T. A., Minor J. R., Fauci A. S. Treatment of Wegener's granulomatosis with intermittent high-dose intravenous cyclophosphamide. Am J Med. 1990 Oct;89(4):403–410. doi: 10.1016/0002-9343(90)90367-m. [DOI] [PubMed] [Google Scholar]
  20. Hoffman G. S., Leavitt R. Y., Kerr G. S., Fauci A. S. The treatment of Wegener's granulomatosis with glucocorticoids and methotrexate. Arthritis Rheum. 1992 Nov;35(11):1322–1329. doi: 10.1002/art.1780351113. [DOI] [PubMed] [Google Scholar]
  21. Jayne D. R., Davies M. J., Fox C. J., Black C. M., Lockwood C. M. Treatment of systemic vasculitis with pooled intravenous immunoglobulin. Lancet. 1991 May 11;337(8750):1137–1139. doi: 10.1016/0140-6736(91)92797-6. [DOI] [PubMed] [Google Scholar]
  22. Masuyama K., Sadanaga Y., Kokumai S., Uno M., Tani E., Samejima Y., Ikawa T., Ogata N., Ishikawa T. Pulse methylprednisolone therapy in the treatment of Wegener's granulomatosis. Auris Nasus Larynx. 1993;20(1):39–45. doi: 10.1016/s0385-8146(12)80209-4. [DOI] [PubMed] [Google Scholar]
  23. Norton W. L., Suki W., Strunk S. Combined corticosteroid and azathioprine therapy in 2 patients with Wegener's granulomatosis. Arch Intern Med. 1968 Jun;121(6):554–560. [PubMed] [Google Scholar]
  24. Palmer A., Cairns T., Dische F., Gluck G., Gjorstrup P., Parsons V., Welsh K., Taube D. Treatment of rapidly progressive glomerulonephritis by extracorporeal immunoadsorption, prednisolone and cyclophosphamide. Nephrol Dial Transplant. 1991;6(8):536–542. doi: 10.1093/ndt/6.8.536. [DOI] [PubMed] [Google Scholar]
  25. Pusey C. D., Gaskin G., Rees A. J. Treatment of primary systemic vasculitis. APMIS Suppl. 1990;19:48–50. doi: 10.1111/j.1600-0463.1990.tb05735.x. [DOI] [PubMed] [Google Scholar]
  26. Rees A. J., Pusey C. D. Plasma exchange in systemic vasculitis. Neth J Med. 1990 Apr;36(3-4):103–106. [PubMed] [Google Scholar]
  27. Richter C., Schnabel A., Csernok E., Reinhold-Keller E., Gross W. L. Treatment of Wegener's granulomatosis with intravenous immunoglobulin. Adv Exp Med Biol. 1993;336:487–489. doi: 10.1007/978-1-4757-9182-2_88. [DOI] [PubMed] [Google Scholar]
  28. Steppat D., Gross W. L. Stage-adapted treatment of Wegener's granulomatosis. First results of a prospective study. Klin Wochenschr. 1989 Jul 3;67(13):666–671. doi: 10.1007/BF01718027. [DOI] [PubMed] [Google Scholar]
  29. Stillwell T. J., Benson R. C., Jr Cyclophosphamide-induced hemorrhagic cystitis. A review of 100 patients. Cancer. 1988 Feb 1;61(3):451–457. doi: 10.1002/1097-0142(19880201)61:3<451::aid-cncr2820610308>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
  30. Tervaert J. W., Huitema M. G., Hené R. J., Sluiter W. J., The T. H., van der Hem G. K., Kallenberg C. G. Prevention of relapses in Wegener's granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre. Lancet. 1990 Sep 22;336(8717):709–711. doi: 10.1016/0140-6736(90)92205-v. [DOI] [PubMed] [Google Scholar]
  31. WILLIAMS H. L., HOCHFILZER J. J. Effect of cortisone on idiopathic granuloma of the midline tissues of the face. Ann Otol Rhinol Laryngol. 1950 Jun;59(2):518–530. doi: 10.1177/000348945005900222. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES